Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Patent Profile: Vermillion Announces Allowance of Ovarian Cancer Biomarker Application

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- Last week, Vermillion, Inc. announced that the U.S. Patent and Trademark Office had issued a Notice of Allowance for its application directed to diagnostic methods using hepcidin as a biomarker for ovarian cancer. The patent that eventually issues from the allowed application will be the Fremont, CA-based molecular diagnostics company's third U.S. patent.A search of the USPTO Published Applications database and Public PAIR suggests that the Notice of Allowance described in Vermillion's press release was mailed for U.S. Application No. 11/373,833, which is entitled "Biomarker for Ovarian and Endometrial Cancer: Hepcidin," and which was published on...

Full post as published by Patent Docs on February 20, 2009 (boomark / email).